Close Menu
    KSA NewslineKSA Newsline
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Porsche to cut 5000 more jobs under restructuring plan

      July 28, 2026

      Japan new car sales rise 1.8% in first half of 2026

      July 2, 2026

      Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

      May 18, 2026

      Mercedes-Benz unveils electric C-Class in Seoul

      April 21, 2026
    • Business

      South Korea’s exports pass $1 trillion for the first time

      November 21, 2026

      Botswana opens consultations on proposed 33 percent hike now

      November 19, 2026

      Rand slips toward R17 as inflation and weak growth cloud outlook

      November 18, 2026

      Prabowo says DEFA can unlock $2 trillion ASEAN digital economy

      November 18, 2026

      Morocco secures €434.4 million AfDB loan for reforms

      November 14, 2026
    • Entertainment

      Sony confirms God of War trilogy remake and PS5 prequel

      February 13, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Moscow hosts historic 47th international festival

      April 19, 2025

      Legal action against ‘Ketamine Queen,’ doctors in Perry overdose

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024
    • Health

      Guinea ends mpox outbreak more than two years after first case

      November 21, 2026

      Ebola adds 60 cases in a day as Congo deaths hit 5,568

      November 18, 2026

      Ebola cases top 11,200 as Africa CDC warns of record outbreak

      November 16, 2026

      Yellow fever kills 18 across nine African nations, WHO says

      November 7, 2026

      Dengue kills 173 in October as Bangladesh toll climbs to 418

      November 2, 2026
    • Lifestyle

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023

      From labels to legacy – understanding fashion’s hierarchy

      August 21, 2023
    • Luxury

      Global luxury market contracts for first time since Great Recession

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      WFP warns funding gaps will leave millions hungry in 2027

      November 21, 2026

      PM Modi meets Prince and Princess of Wales for climate talks

      November 19, 2026

      Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

      November 17, 2026

      Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

      November 16, 2026

      Sheikh Mohamed receives Arab League chief Nabil Fahmy

      November 14, 2026
    • Sports

      Dakar 2026 Youth Olympic Games open Saturday in Senegal

      October 30, 2026

      Ballon d’Or 2026 nominees confirmed for London ceremony

      September 9, 2026

      Lionel Messi retires from Argentina after 21-year record run

      September 1, 2026

      Portugal fall to Spain as Ronaldo legacy closes

      July 7, 2026

      Brazil exits World Cup after Norway Round of 16 victory

      July 6, 2026
    • Technology

      MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

      November 3, 2026

      Sam Altman calls UAE most forward-looking country on AI

      November 3, 2026

      Apple iPhone Duo sets a new benchmark for foldable design

      November 2, 2026

      Apple brings Touch and PROLED XDR display to MacBook Pro

      October 29, 2026

      Integrated Identity Enters Global Top 0.1% with Rare 100/100 Google PageSpeed

      October 29, 2026
    • Travel

      Air Arabia Egypt launches Cairo to Al Ain flights soon

      November 20, 2026

      Dubai Airports expects over 70 million guests in 2026

      November 18, 2026

      Over 9 million visitors lift Tunisia tourism income 3.4%

      November 17, 2026

      Türkiye aims to rank sixth in global tourism revenue

      October 21, 2026

      Air Arabia launches Sharjah flights to Amman City Airport

      October 9, 2026
    KSA NewslineKSA Newsline
    Home » Novel pill halts tumor growth offering new hope in cancer treatment
    Health

    Novel pill halts tumor growth offering new hope in cancer treatment

    August 3, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Researchers at City of Hope in California have made a significant breakthrough in cancer treatment, developing a pill named AOH1996, with the potential to eradicate various forms of solid tumors. The novel medicine shows promising results in preliminary studies, proving effective against cancer cells sourced from breast, prostate, brain, ovarian, cervical, skin, and lung cancers. The pill pays tribute to Anna Olivia Healy, born in 1996 and tragically passed away at age nine from neuroblastoma, a rare childhood cancer.

    This medical innovation departs from typical targeted therapies, which often focus on one pathway, allowing cancer to eventually mutate and develop resistance. Instead, AOH1996 targets a protein called proliferating cell nuclear antigen (PCNA), crucial for DNA replication and the repair of cancerous cells, thus promoting tumor growth. According to Professor Linda Malkas from City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics, this pill functions as an effective countermeasure, disrupting PCNA operations specifically within cancer cells, akin to a snowstorm closing a major airline terminal.

    The study published in the journal Cell Chemical Biology reveals that AOH1996 effectively suppresses tumor growth, working as a standalone treatment or in combination with other therapies. It selectively targets cancer cells, disrupting their normal reproductive cycles, while sparing healthy stem cells. The pill zeroes in on transcription replication conflicts, which occur when the gene expression and genome duplication mechanisms collide, leading to apoptosis or cancer cell death.

    With promising results from cell and animal model testing, a Phase 1 clinical trial in humans is now in progress. Researchers have discovered that PCNA contributes to increased replication errors in cancer cells. This discovery offers new avenues to develop more personalized, targeted cancer treatments. Further tests have shown that the experimental pill increases the vulnerability of cancer cells to DNA-damaging agents like the chemotherapy drug cisplatin, suggesting the potential for AOH1996 to be instrumental in combination therapies and the development of novel chemotherapeutics.

    Cancer continues to be a major global health concern, with the World Health Organization (WHO) estimating that it was responsible for nearly 10 million deaths worldwide in 2020 alone. This staggering figure highlights the ongoing urgency to develop more effective and targeted treatments like AOH1996. In the United States, the American Cancer Society projected that there would be over 600,000 cancer deaths in 2021. This devastating reality underscores the critical importance of novel therapies and treatments, such as the AOH1996 pill, in the fight against this pervasive disease.

    Breast, lung, colorectal, and prostate cancers are among the leading types of cancer in terms of incidence, and lung cancer is the most common cause of cancer death. Given that the AOH1996 pill has shown efficacy against cells from many types of cancers, including breast, prostate, and lung, the potential impact of this breakthrough on patient outcomes could be significant.

    However, it’s crucial to note that this is still a preliminary study, and the pill is yet to be tested extensively in humans. While the initial results are promising, further research and clinical trials are necessary to confirm its safety and efficacy in humans. Despite the challenges ahead, the development of the AOH1996 pill represents an exciting and potentially revolutionary advancement in cancer treatment.

    Related Posts

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

    November 2, 2026
    Latest News

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    Guinea has officially ended its mpox outbreak, more than two years after the country confirmed its first case of the disease. Health Minister Khaite Sall announced the decision on Thursday, November 19, in an official statement read on national television.

    WFP warns funding gaps will leave millions hungry in 2027

    November 21, 2026

    South Korea’s exports pass $1 trillion for the first time

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    November 20, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales for climate talks

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026
    © 2026 KSA Newsline | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.